Profile data is unavailable for this security.
About the company
Sopharma Trading AD (Sofarma Trading AD) is a Bulgaria-based company that is principally engaged in the distribution and wholesale of pharmaceuticals, drugs, medical supplies and facilities, food additives, vitamins and disinfectants. Its product portfolio includes more than 7,000 items. The Company operates warehouses and regional distributive centers in five cities in Bulgaria, the Company supplies its products to pharmacies, hospitals, clinics and other health care facilities. Sopharma Trading AD Sofia is a part of the Sopharma Group. As of December 31, 2011, the Company’s major shareholder was Sopharma AD with a stake of 81.33%.
- Revenue in BGN (TTM)1.73bn
- Net income in BGN31.54m
- Incorporated2005
- Employees2.73k
- LocationSopharma Trading ADul. Lachezar Stanchev No. 5Sofarma Biznes Tauars, Sgrada A, et. 12SOFIA 1756BulgariaBGR
- Phone+359 28133660
- Fax+359 28133666
- Websitehttps://www.sopharmatrading.com/?lang=bg
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Harima-Kyowa Co., LTD. | 705.79m | 16.12m | 130.34m | 197.00 | 7.98 | 0.4655 | 7.80 | 0.1847 | 261.75 | 261.75 | 11,459.40 | 4,490.24 | 1.91 | 23.79 | 5.51 | -- | 4.36 | 4.39 | 5.70 | 5.87 | 11.57 | 11.73 | 2.28 | 2.23 | 2.22 | -- | 0.0131 | 17.15 | 2.37 | 5.01 | 1.10 | 3.25 | 34.30 | 3.44 |
| Balaxi Pharmaceuticals Ltd | 52.13m | -515.71k | 141.94m | 51.00 | -- | 3.22 | -- | 2.72 | -0.566 | -0.566 | 46.75 | 36.96 | 0.969 | 1.37 | 4.47 | -- | -0.9586 | 19.81 | -1.22 | 27.30 | 46.67 | 35.46 | -0.9893 | 11.95 | 2.36 | 26.61 | 0.0879 | -- | -28.28 | 77.76 | -105.19 | -- | 5.11 | -- |
| Natural Health Trends Corp. | 77.55m | 899.67k | 143.48m | 138.00 | 159.11 | 2.02 | 122.06 | 1.85 | 0.0434 | 0.0434 | 3.75 | 3.42 | 0.582 | 2.24 | -- | 311,695.70 | 0.6751 | -0.5398 | 0.9333 | -0.7099 | 74.30 | 74.06 | 1.16 | -0.9571 | 2.77 | -- | 0.00 | -- | -10.60 | -25.54 | 81.47 | -54.86 | -26.47 | 6.64 |
| 111 Inc - ADR | 3.68bn | -93.29m | 182.01m | 1.52k | -- | -- | -- | 0.0495 | -0.6106 | -0.6106 | 24.07 | -1.04 | 4.80 | 9.62 | 32.62 | 1,342,754.00 | -10.93 | -17.09 | -- | -178.25 | 5.56 | 5.36 | -2.28 | -4.37 | 0.5234 | -19.99 | 0.4256 | -- | 10.59 | 52.95 | 5.80 | -- | -7.89 | -- |
| Pharmaniaga Berhad | 1.30bn | -29.67m | 198.74m | 3.78k | -- | -- | -- | 0.1524 | -0.0572 | -0.0572 | 2.55 | -0.2056 | 1.82 | 4.59 | 9.57 | -- | -4.06 | -6.88 | -- | -38.45 | 9.04 | 6.64 | -2.23 | -3.66 | 0.2762 | 1.37 | 1.29 | -- | -3.02 | 7.38 | 87.25 | -- | 23.35 | -- |
| Sopharma Trading AD | 1.73bn | 31.54m | 200.51m | 2.73k | 6.36 | 1.47 | 3.13 | 0.1158 | 0.9201 | 0.9201 | 50.50 | 3.98 | 2.66 | 0.1586 | 7.16 | 661,702.60 | 4.85 | 2.39 | 14.87 | 7.88 | 97.98 | 98.09 | 1.82 | 1.01 | 0.6231 | 185.95 | 0.6107 | -- | 13.02 | 13.26 | 221.67 | 27.86 | 3.70 | -- |
| Profarma Distribuidora de Produts Frm SA | 3.06bn | 26.50m | 224.29m | 7.08k | 8.38 | 0.5151 | 2.73 | 0.0734 | 0.6289 | 0.6289 | 72.50 | 10.23 | 1.77 | 4.67 | 7.67 | -- | 1.70 | 1.64 | 4.06 | 3.40 | 14.97 | 14.61 | 0.9618 | 0.9519 | 0.7696 | 1.85 | 0.4552 | -- | 10.82 | 15.19 | -12.95 | -- | 41.08 | -- |
| Charmacy Pharmaceutical Co Ltd | 1.10bn | 12.80m | 233.35m | 831.00 | 18.23 | 1.57 | 12.03 | 0.2126 | 0.5139 | 0.5139 | 44.07 | 5.98 | 1.44 | 6.05 | 4.88 | 5,728,231.00 | 1.68 | 1.79 | 8.28 | 7.99 | 6.34 | 6.08 | 1.17 | 1.24 | 0.7775 | 2.79 | 0.5111 | 37.09 | 5.47 | 2.27 | -43.25 | 2.48 | -16.01 | 0.0027 |
| EQL Pharma AB | 45.24m | 3.89m | 261.81m | 21.00 | 68.83 | 8.60 | -- | 5.79 | 0.7642 | 0.7642 | 8.88 | 6.12 | 0.8012 | 1.74 | 4.80 | 12,579,430.00 | 6.89 | 9.02 | 11.90 | 15.27 | 43.55 | 37.95 | 8.59 | 8.29 | 0.5694 | 8.88 | 0.4032 | -- | 1.64 | 39.64 | -26.57 | -- | 32.73 | -- |
Data as of May 31 2024. Currency figures normalised to Sopharma Trading AD's reporting currency: BGN
1.26%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| KBC Asset Management NVas of 30 Jun 2023 | 431.91k | 1.26% |
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
